Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

THTX

Theratechnologies (THTX)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:THTX
DataOraFonteTitoloSimboloCompagnia
19/12/202421:55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:THTXTheratechnologies Inc
18/12/202419:30GlobeNewswire Inc.Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing EnvironmentNASDAQ:THTXTheratechnologies Inc
10/12/202421:15GlobeNewswire Inc.Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation sBLANASDAQ:THTXTheratechnologies Inc
09/12/202413:30GlobeNewswire Inc.Theratechnologies Announces Preliminary Tolerability and Efficacy Data from Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients with Advanced Ovarian CancerNASDAQ:THTXTheratechnologies Inc
04/12/202413:30GlobeNewswire Inc.Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in CanadaNASDAQ:THTXTheratechnologies Inc
03/12/202422:30GlobeNewswire Inc.Theratechnologies Announces Resumed Production of EGRIFTA SV®NASDAQ:THTXTheratechnologies Inc
02/12/202413:30GlobeNewswire Inc.Theratechnologies Secures up to $75 Million in New Credit Facilities with TD Bank and Investissement QuébecNASDAQ:THTXTheratechnologies Inc
26/11/202413:30GlobeNewswire Inc.Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA ReviewNASDAQ:THTXTheratechnologies Inc
17/10/202420:00GlobeNewswire Inc.Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIVNASDAQ:THTXTheratechnologies Inc
17/10/202413:30GlobeNewswire Inc.Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug ResistanceNASDAQ:THTXTheratechnologies Inc
10/10/202413:30GlobeNewswire Inc.Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024NASDAQ:THTXTheratechnologies Inc
10/10/202412:48IH Market NewsU.S. Futures Fall Slightly as Investors Await CPI Data; Oil Prices RiseNASDAQ:THTXTheratechnologies Inc
09/10/202413:30GlobeNewswire Inc.Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIVNASDAQ:THTXTheratechnologies Inc
26/09/202413:30GlobeNewswire Inc.Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
17/09/202423:00GlobeNewswire Inc.Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025NASDAQ:THTXTheratechnologies Inc
09/09/202413:30GlobeNewswire Inc.Theratechnologies to Present at Upcoming Investor Conferences in SeptemberNASDAQ:THTXTheratechnologies Inc
10/07/202413:30GlobeNewswire Inc.Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024NASDAQ:THTXTheratechnologies Inc
10/07/202412:43IH Market NewsU.S. Index Futures Climb; Oil Prices RecoverNASDAQ:THTXTheratechnologies Inc
26/06/202413:30GlobeNewswire Inc.Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
23/05/202423:00GlobeNewswire Inc.Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid TumorsNASDAQ:THTXTheratechnologies Inc
09/05/202422:30GlobeNewswire Inc.Theratechnologies Reports on its Annual Meeting of ShareholdersNASDAQ:THTXTheratechnologies Inc
02/05/202413:30GlobeNewswire Inc.Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO MeetingNASDAQ:THTXTheratechnologies Inc
15/04/202422:15GlobeNewswire Inc.Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of ShareholdersNASDAQ:THTXTheratechnologies Inc
11/04/202413:30GlobeNewswire Inc.Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:THTXTheratechnologies Inc
10/04/202413:30GlobeNewswire Inc.Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024NASDAQ:THTXTheratechnologies Inc
10/04/202413:15IH Market NewsU.S. Index Futures Show Mixed Trend Ahead of Key Inflation Data Release, Oil Prices Edge HigherNASDAQ:THTXTheratechnologies Inc
08/04/202422:30GlobeNewswire Inc.Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology PlatformNASDAQ:THTXTheratechnologies Inc
05/04/202417:00GlobeNewswire Inc.Theratechnologies Appoints Elina Tea to its Board of DirectorsNASDAQ:THTXTheratechnologies Inc
03/04/202413:30GlobeNewswire Inc.Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:THTXTheratechnologies Inc
28/03/202412:30GlobeNewswire Inc.Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ PlatformNASDAQ:THTXTheratechnologies Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:THTX
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network